Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Transcriptome Analysis Reveals Pattern of Gene Expression with Diagnostic Potential for Lyme Disease

By LabMedica International staff writers
Posted on 22 Feb 2016
A distinctive gene expression pattern exists during a three week period following infection with the bacterium Borrelia burgdorferi that enables definitive diagnosis of Lyme disease.

Lyme disease is the most common tick-borne infection in the United States, and some patients report lingering symptoms lasting months to years despite antibiotic treatment. More...
To better understand the role of the human host response in acute Lyme disease and the development of post-treatment symptoms, investigators at the University of California, San Francisco (USA) and John Hopkins University (Baltimore, MD, USA), conducted a longitudinal gene expression (transcriptome) study of patients enrolled at the time of diagnosis and followed up for up to six months after treatment.

The investigators used the RNA-seq next-generation sequencing technique to define the pattern of gene expression (the transcriptome) in the white blood cells of 29 Lyme disease patients before and after they received a three-week course of antibiotic treatment and also six months later. A group of 13 matched control subjects were tested in parallel with the Lyme disease patients.

Results revealed that the differential gene expression signature of Lyme disease following the acute phase of infection persisted for at least three weeks and had fewer than 44% differentially expressed genes (DEGs) in common with other infectious or noninfectious syndromes. Early Lyme disease prior to antibiotic therapy was characterized by marked upregulation of Toll-like receptor signaling but lack of activation of the inflammatory T-cell apoptotic and B-cell developmental pathways seen in other acute infectious syndromes.

Six months after completion of therapy, Lyme disease patients were found to have 31% to 60% of their pathways in common with three different immune-mediated chronic diseases: systematic lupus erythematosus, rheumatoid arthritis, and chronic fatigue syndrome. No differential gene expression signature was observed between Lyme disease patients with resolved illness to those with persistent symptoms at six months post-treatment.

"Improved diagnostics are urgently needed for Lyme disease," said senior author Dr. Charles Chiu, associate professor of laboratory medicine at the University of California, San Francisco. "The tick that transmits Lyme also harbors many other pathogens, and early diagnosis is critical in guiding appropriate treatment and preventing later complications of the illness."

"To our knowledge, this study is the first to document changes in gene expression occurring even after a bacterial infection has been treated with appropriate antibiotics," said contributing author Dr. John Aucott, assistant professor of medicine at Johns Hopkins University.

The study was published in the February 12, 2016, online edition of the journal mBio.

Related Links:
University of California, San Francisco
John Hopkins University


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.